The Clinical Implications of Tumor Mutational Burden in Osteosarcoma

BACKGROUND: Osteosarcoma (OTS) is aggressive bone malignancy without well-recognized prognosis biomarker. Tumor mutational burden (TMB) has been proved as effective biomarker in predicting clinical outcomes in several cancer types. However, its prognostic value in OTS remains unknown. In this study,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Xie, Lu, Yang, Yufei, Guo, Wei, Che, Dongxue, Xu, Jie, Sun, Xin, Liu, Kuisheng, Ren, Tingting, Liu, Xingyu, Yang, Yi, Ji, Tao, Tang, Xiaodong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8059407/
https://ncbi.nlm.nih.gov/pubmed/33898301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.595527
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi